USPTO serial 88245461
AVENIR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 10, 2020
- Examiner
- LAPTER, ALAIN J
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with AVENIR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Laguna Hills, CA, US
Laguna Hills, CA, US
Laguna Hills, CA, US
SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.
SHANGHAI, CN
Other trademarks owned by SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Helen Liu
Helen Liu LIU LAW OFFICE8 JONATHAN LANEBEDFORD, MA 01730United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices for use in treating or diagnosing vascular abnormalities, namely, devices for endovascular occlusion of neurovascular and peripheral vascular structures; Medical devices for use in treating or diagnosing vascular disease, namely, microcatheters, guiding catheters and sheaths, removal rings, catheters, aspiration pumps, pump tubing and pump canisters; Medical devices for use in treating or diagnosing intracranial aneurysms, neurovascular abnormalities, or arterial and venous embolizations in the peripheral vasculature; Medical devices for use in treating or diagnosing by removing thrombus material from vessels; or with the use of peripheral, neurovascular coils, or embolic coils; Medical devices to treat intravascular sites; Medical devices, namely, intravascular implants comprised of artificial material; Medical devices, namely, minimally invasive neurovascular devices for the treatment of neurological conditions | ACTIVE | Aug 4, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Wallaby Medical, Inc.
- Other trademarks owned by Wallaby Medical, Inc.
- Other trademarks owned by Wallaby Medical, Inc.
- Other trademarks owned by SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.
- Other trademarks in Class 010
- Similar marks named AVENIR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2026 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jul 13, 2026 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jul 13, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 28, 2026 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Mar 10, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 6, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 10, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 6, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 5, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 31, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 31, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 13, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jan 13, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 16, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 21, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 21, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 21, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 21, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 21, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2019 | NWAP | NEW APPLICATION ENTERED | — |